Clearmind Medicine Inc. (CMND) stock
CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)
Close on Nov 18, 2026Market cap $484.50KP/E –Yield –
Clearmind Medicine shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Clearmind Medicine's shares outstanding was 2M at Jul 31, 2026. For fiscal 2025 it was 0M, up 64.0% from the year before. The highest annual figure on record is 0M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | 0M | +64.0% |
| FY2024 | Oct 31, 2024 | 0M | +1431.1% |
| FY2023 | Oct 31, 2023 | 0M | +367.4% |
| FY2022 | Oct 31, 2022 | 0M | +40.1% |
| FY2021 | Oct 31, 2021 | 0M | +70.6% |
| FY2020 | Oct 31, 2020 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | 2M | +11549.9% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | 0M | +2298.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | 1M | +935.6% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | 0M | +34.1% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | 0M | -84.7% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | 0M | -84.5% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | 0M | +195.8% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | 0M | +998.5% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | 0M | +1406.6% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | 0M | +2504.3% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | 0M | +1881.0% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | 0M | +751.1% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | 0M | +466.3% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | 0M | – |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | 0M | – |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | 0M | – |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | 0M | – |
See a number that looks wrong?